Mendelspod Podcast
The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
- Update frequency
- every 5 days
- Average duration
- 27 minutes
- Episodes
- 505
- Years Active
- 2014 - 2025
We Need a Google Maps for Metagenomics, Says Rob Knight, UCSD
When will we see the results of microbiome research in our every day lives? And what will that look like?
Rob Knight joins us for the first time today. He’s a professor at UC San Diego and Director …
Rob Knight joins us for the first time today. He’s a professor at UC San Diego and Director …
00:21:44 |
Tue 27 Jun 2017
Move Over PDL1: New Test Combo Adds RNAseq to Better Track Immune Escape
Reports from ASCO, the nation’s biggest cancer conference, this year again were full of stunning stories about the success of older and new immuno therapies. The race has never been hotter for bioma…
00:20:49 |
Thu 22 Jun 2017
The Last Major Disease To Be Studied? Ron Davis of Stanford Thinks So
Let’s say you’re a biomedical researcher looking for a place to make your mark. You find out that there is still a major disease that affects more than 2 million people in the US, and we still know…
00:26:40 |
Thu 15 Jun 2017
On Bioinformatics Data Sharing and Collaboration: Andrew Carroll, DNAnexus
What does it take to collaborate in genomics?
A platform, for one thing. Over the past few years bioinformaticians have been speculating about a dominant "go to” site that would serve the software ne…
A platform, for one thing. Over the past few years bioinformaticians have been speculating about a dominant "go to” site that would serve the software ne…
00:28:47 |
Thu 08 Jun 2017
Grail Merger, Genomic Autopsies, Overtreatment Alarm, and Controversy at Ancestry.com: May 2017 Review with Nathan and Laura
Is Grail already merging? Genomic autopsies? Does the House's new healthcare bill turn mere genetic risk into pre-conditions? Nathan and Laura are back to find meaning in the rush of May's headline…
00:23:15 |
Thu 01 Jun 2017
Is Population Medicine Failing Us? Michel Accad
Is health the same thing for an individual as it is for a population? This question goes to the foundation of how we practice medicine today and that of most of genomic research.
Michel Accad is a car…
Michel Accad is a car…
00:25:05 |
Thu 25 May 2017
Deep Omics Profiler, Mike Snyder, Now Turns to Wearables
Mike Snyder is well known in the genomics community for his iPOP (integrated personal omics profiling) study. Profiling himself with hundreds of thousands of measurements each day over a period of se…
00:30:10 |
Thu 18 May 2017
Over $1 Billion Invested this Past Year: Synthetic Biology in 2017 with John Cumbers
What does it take to make it in synthetic biology in 2017?
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/sub…
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/sub…
00:27:23 |
Thu 11 May 2017
Green Light for DTC, Blood Mammograms, and Ancient DNA: April 2017 with Nathan and Laura
For genomics nerds, April 2017 will be remembered as the date when the FDA adopted a more open policy towards 23andMe and direct-to-consumer (DTC) genetic testing. What does this decision mean, and…
00:22:23 |
Mon 01 May 2017
With 50 Million Users, Is Academia.edu Speeding Up Science?
Today we follow up with Richard Price, the founder and CEO of the most popular social sharing site for the academic sector, Academia.edu. When we talked to Richard almost five years ago, the site …
00:28:26 |
Tue 18 Apr 2017
How to Improve Lab Tests in the Absence of FDA Regulation?
Rubbing shoulders at molecular medicine conferences these days one senses a sigh of relief when you talk about laboratory developed tests (LDTs). With the FDA’s decision to put regulation on hold co…
00:21:22 |
Thu 13 Apr 2017
Known for Medical Devices, 116 Yr Old BD Makes a Bold Move in Genomics
Talk to someone who attended this year’s AGBT, and you’ll know the big buzz was about single cell genomics. One of the exciting new platforms came from a new player in the genomics space and yet fro…
00:18:50 |
Wed 05 Apr 2017
Proposed NIH Cuts, Undermining GINA, and Game Changing Drugs: March 2017 with Nathan and Laura
The largest cut to NIH budget ever, rolling back genetic non-discriminatory law—the bad news continues to roll from Washington. But there was great news this month as well.
This is a public episode.…
This is a public episode.…
00:20:41 |
Fri 31 Mar 2017
Art in the Lab (Falling in Love with Bacteria)
Today’s guest makes time to create beauty in the lab. Memo Berkmen is a bacterial artist along with being a staff scientist at New England Bio Labs. He and his colleague, Maria Penil, were the winner…
00:19:23 |
Tue 28 Mar 2017
Flint Whistleblower Says Today's Science Is to Blame for Its Own Lack of Public Trust
Marc Edwards is telling a different story than the one most of us have been reading and hearing lately. But then he’s used to it.
Marc was the engineer from Virginia Tech who was called one day in Se…
Marc was the engineer from Virginia Tech who was called one day in Se…
00:27:29 |
Thu 16 Mar 2017
The Story of Geisinger and Doing Genomic Medicine at the Right Pace
Mike Murray and the crew over at Geisinger are making the implementation of genomic medicine look down right easy.
In today’s interview, Mike explains GenomeFIRST Medicine, a program at the Geisinger …
In today’s interview, Mike explains GenomeFIRST Medicine, a program at the Geisinger …
00:24:12 |
Wed 08 Mar 2017
In-Situ Sequencing, CRISPR Patents, and Racist Milk Drinkers: February 2017 with Nathan and Laura
Commentators Nathan Pearson and Laura Hercher join us to look back on February’s genomics headlines.
Beginning this time with science, Nathan says we should be expecting great things from new in-situ …
Beginning this time with science, Nathan says we should be expecting great things from new in-situ …
00:23:33 |
Wed 01 Mar 2017
New Pocket Size Nanopore Device Could Revolutionize Diagnostic and Other Testing
First of all, watch the video below.
A Santa Cruz company is now previewing a nanopore device that could be a major disruptor in molecular testing. The device is the size of a glucometer and could ta…
A Santa Cruz company is now previewing a nanopore device that could be a major disruptor in molecular testing. The device is the size of a glucometer and could ta…
00:18:52 |
Mon 20 Feb 2017
By Changing a Basic Lab Step, Acoustic Liquid Transfer Having a Broad Impact
Freeman Dyson famously said, “the great advances in science usually result from new tools rather than from new doctrine.”
Today we talk with Mark Fischer-Colbrie, CEO of Labcyte, a company which has m…
Today we talk with Mark Fischer-Colbrie, CEO of Labcyte, a company which has m…
00:21:36 |
Mon 13 Feb 2017
Many Biologists Today Don’t Have Enough Computer Science to Use the Databases
Moray Campbell was for all intents and purposes an accomplished and successful cancer biologist at the renowned Roswell Park Cancer Center. Then one day he woke up and realized he was becoming irrel…
00:25:40 |
Thu 09 Feb 2017
Disclaimer: The podcast and artwork embedded on this page are the property of Theral Timpson. This content is not affiliated with or endorsed by eachpod.com.